English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Hepatic encephalopathy is a reversible neuro-psychiatric syndrome occurring in majority of patients with decompensated chronic liver disease(CLD). Prognosis of Hepatic encephalopathy (HE) depends upon past h/o hematemesis/ melena and HE but not related to the aetiology of CLD. Rifaximin and lactulose have similar efficacy for treatment of acute HE . Purpose of this study is to compare the effectiveness of 3 modes of treatment for 7 days in terms of clinical improvement / deterioration who have or have not past h/o hematemesis/ melenaand or HE. Material and methods: After ethical clearance and consent from patient parties, 90 patients of HE of any cause and grade with or without past h/o hematemesis/melena and or HE, were categorise into different grades according to West Haven criteria and randomised to treat for 7 days with divided doses by either rifaximin 30 patients, lactulose 30 patients , rifaximin plus lactulose 30 patients. At the end, clinical improvement and deterioration were noticed. Results: Alcoholic CLD (63.33%) was the commonest. Clinical deterioration were commoner in chronic HCV (66.67%) than chronic HBV, alcoholic CLD. Patients with past h/o hematemesis /melena, clinical deterioration and improvement were 26.92% and 73.08% but without such , clinical deterioration and improvement were 2.63% and 97.37% . Patients with past h/o HE , clinical deterioration and improvement were 31.25% and 68.75% but without such past illness, clinical deteriorations and improvements were 0 and 100% . Conclusion: So clinical outcome is better in patients of HE without past h/o HE and hematemesis/melena. Keyword: Hepatic encephalopathy , chronic liver disease ,Rifaximin,Lactulose

iosr journal of dental and medical sciences

A Comparative Study to Determine the Outcome of Hepatic Encephalopathy who Have A Past History of Hepatic Encephalopathy And or Upper Gastrointestinal Bleeding Versus Who Have Not Such Using 7 Days Therapy of RifaximinAnd or Lactulose